カテゴリー： Market Monitor Global, 世界, 医療/バイオ

甲状腺機能低下症治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Hypothyroidism Drugs Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8792 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：116 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Hypothyroidism Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの甲状腺機能低下症治療薬市場規模と予測を収録しています。・世界の甲状腺機能低下症治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の甲状腺機能低下症治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の甲状腺機能低下症治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「非経口」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

甲状腺機能低下症治療薬のグローバル主要企業は、Eli Lilly、 Pfizer、 AbbVie、 Novo Nordisk、 Merck KGaA、 Mylan、 Bayer、 Teva、 Novartis、 Abbott、 Roche、 Endo International、 Ipsen、 ANI Pharmaceuticals、 TherapeuticsMDなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、甲状腺機能低下症治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の甲状腺機能低下症治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の甲状腺機能低下症治療薬市場：タイプ別市場シェア、2022年
・非経口、経皮、経口、その他

世界の甲状腺機能低下症治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の甲状腺機能低下症治療薬市場：用途別市場シェア、2022年
・病院、ドラッグストア、その他

世界の甲状腺機能低下症治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の甲状腺機能低下症治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における甲状腺機能低下症治療薬のグローバル売上、2018年-2023年
・主要企業における甲状腺機能低下症治療薬のグローバル売上シェア、2022年
・主要企業における甲状腺機能低下症治療薬のグローバル販売量、2018年-2023年
・主要企業における甲状腺機能低下症治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Eli Lilly、 Pfizer、 AbbVie、 Novo Nordisk、 Merck KGaA、 Mylan、 Bayer、 Teva、 Novartis、 Abbott、 Roche、 Endo International、 Ipsen、 ANI Pharmaceuticals、 TherapeuticsMD

*************************************************************

・調査・分析レポートの概要
甲状腺機能低下症治療薬市場の定義
市場セグメント
世界の甲状腺機能低下症治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の甲状腺機能低下症治療薬市場規模
世界の甲状腺機能低下症治療薬市場規模：2022年 VS 2029年
世界の甲状腺機能低下症治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの甲状腺機能低下症治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の甲状腺機能低下症治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：非経口、経皮、経口、その他
甲状腺機能低下症治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、ドラッグストア、その他
甲状腺機能低下症治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別甲状腺機能低下症治療薬市場規模 2022年と2029年
地域別甲状腺機能低下症治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Eli Lilly、 Pfizer、 AbbVie、 Novo Nordisk、 Merck KGaA、 Mylan、 Bayer、 Teva、 Novartis、 Abbott、 Roche、 Endo International、 Ipsen、 ANI Pharmaceuticals、 TherapeuticsMD
...

Hypothyroidism (underactive thyroid) is a condition in which your thyroid gland doesn’t produce enough of certain crucial hormones.
This report aims to provide a comprehensive presentation of the global market for Hypothyroidism Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hypothyroidism Drugs. This report contains market size and forecasts of Hypothyroidism Drugs in global, including the following market information:
Global Hypothyroidism Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hypothyroidism Drugs Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Hypothyroidism Drugs companies in 2022 (%)
The global Hypothyroidism Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Parenteral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hypothyroidism Drugs include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hypothyroidism Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hypothyroidism Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Hypothyroidism Drugs Market Segment Percentages, by Type, 2022 (%)
Parenteral
Transdermal
Oral
Others
Global Hypothyroidism Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Hypothyroidism Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Drugstores
Others
Global Hypothyroidism Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Hypothyroidism Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hypothyroidism Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hypothyroidism Drugs revenues share in global market, 2022 (%)
Key companies Hypothyroidism Drugs sales in global market, 2018-2023 (Estimated), (Units)
Key companies Hypothyroidism Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hypothyroidism Drugs, market overview.
Chapter 2: Global Hypothyroidism Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Hypothyroidism Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hypothyroidism Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hypothyroidism Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Hypothyroidism Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hypothyroidism Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hypothyroidism Drugs Overall Market Size
2.1 Global Hypothyroidism Drugs Market Size: 2022 VS 2029
2.2 Global Hypothyroidism Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hypothyroidism Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Hypothyroidism Drugs Players in Global Market
3.2 Top Global Hypothyroidism Drugs Companies Ranked by Revenue
3.3 Global Hypothyroidism Drugs Revenue by Companies
3.4 Global Hypothyroidism Drugs Sales by Companies
3.5 Global Hypothyroidism Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hypothyroidism Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hypothyroidism Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hypothyroidism Drugs Players in Global Market
3.8.1 List of Global Tier 1 Hypothyroidism Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Hypothyroidism Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hypothyroidism Drugs Market Size Markets, 2022 & 2029
4.1.2 Parenteral
4.1.3 Transdermal
4.1.4 Oral
4.1.5 Others
4.2 By Type – Global Hypothyroidism Drugs Revenue & Forecasts
4.2.1 By Type – Global Hypothyroidism Drugs Revenue, 2018-2023
4.2.2 By Type – Global Hypothyroidism Drugs Revenue, 2024-2029
4.2.3 By Type – Global Hypothyroidism Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Hypothyroidism Drugs Sales & Forecasts
4.3.1 By Type – Global Hypothyroidism Drugs Sales, 2018-2023
4.3.2 By Type – Global Hypothyroidism Drugs Sales, 2024-2029
4.3.3 By Type – Global Hypothyroidism Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Hypothyroidism Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hypothyroidism Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application – Global Hypothyroidism Drugs Revenue & Forecasts
5.2.1 By Application – Global Hypothyroidism Drugs Revenue, 2018-2023
5.2.2 By Application – Global Hypothyroidism Drugs Revenue, 2024-2029
5.2.3 By Application – Global Hypothyroidism Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Hypothyroidism Drugs Sales & Forecasts
5.3.1 By Application – Global Hypothyroidism Drugs Sales, 2018-2023
5.3.2 By Application – Global Hypothyroidism Drugs Sales, 2024-2029
5.3.3 By Application – Global Hypothyroidism Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Hypothyroidism Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hypothyroidism Drugs Market Size, 2022 & 2029
6.2 By Region – Global Hypothyroidism Drugs Revenue & Forecasts
6.2.1 By Region – Global Hypothyroidism Drugs Revenue, 2018-2023
6.2.2 By Region – Global Hypothyroidism Drugs Revenue, 2024-2029
6.2.3 By Region – Global Hypothyroidism Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Hypothyroidism Drugs Sales & Forecasts
6.3.1 By Region – Global Hypothyroidism Drugs Sales, 2018-2023
6.3.2 By Region – Global Hypothyroidism Drugs Sales, 2024-2029
6.3.3 By Region – Global Hypothyroidism Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hypothyroidism Drugs Revenue, 2018-2029
6.4.2 By Country – North America Hypothyroidism Drugs Sales, 2018-2029
6.4.3 US Hypothyroidism Drugs Market Size, 2018-2029
6.4.4 Canada Hypothyroidism Drugs Market Size, 2018-2029
6.4.5 Mexico Hypothyroidism Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hypothyroidism Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Hypothyroidism Drugs Sales, 2018-2029
6.5.3 Germany Hypothyroidism Drugs Market Size, 2018-2029
6.5.4 France Hypothyroidism Drugs Market Size, 2018-2029
6.5.5 U.K. Hypothyroidism Drugs Market Size, 2018-2029
6.5.6 Italy Hypothyroidism Drugs Market Size, 2018-2029
6.5.7 Russia Hypothyroidism Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Hypothyroidism Drugs Market Size, 2018-2029
6.5.9 Benelux Hypothyroidism Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hypothyroidism Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Hypothyroidism Drugs Sales, 2018-2029
6.6.3 China Hypothyroidism Drugs Market Size, 2018-2029
6.6.4 Japan Hypothyroidism Drugs Market Size, 2018-2029
6.6.5 South Korea Hypothyroidism Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Hypothyroidism Drugs Market Size, 2018-2029
6.6.7 India Hypothyroidism Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hypothyroidism Drugs Revenue, 2018-2029
6.7.2 By Country – South America Hypothyroidism Drugs Sales, 2018-2029
6.7.3 Brazil Hypothyroidism Drugs Market Size, 2018-2029
6.7.4 Argentina Hypothyroidism Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hypothyroidism Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hypothyroidism Drugs Sales, 2018-2029
6.8.3 Turkey Hypothyroidism Drugs Market Size, 2018-2029
6.8.4 Israel Hypothyroidism Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Hypothyroidism Drugs Market Size, 2018-2029
6.8.6 UAE Hypothyroidism Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Hypothyroidism Drugs Major Product Offerings
7.1.4 Eli Lilly Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Hypothyroidism Drugs Major Product Offerings
7.2.4 Pfizer Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Hypothyroidism Drugs Major Product Offerings
7.3.4 AbbVie Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Hypothyroidism Drugs Major Product Offerings
7.4.4 Novo Nordisk Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 Merck KGaA
7.5.1 Merck KGaA Company Summary
7.5.2 Merck KGaA Business Overview
7.5.3 Merck KGaA Hypothyroidism Drugs Major Product Offerings
7.5.4 Merck KGaA Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Merck KGaA Key News & Latest Developments
7.6 Mylan
7.6.1 Mylan Company Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Hypothyroidism Drugs Major Product Offerings
7.6.4 Mylan Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Mylan Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Hypothyroidism Drugs Major Product Offerings
7.7.4 Bayer Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Bayer Key News & Latest Developments
7.8 Teva
7.8.1 Teva Company Summary
7.8.2 Teva Business Overview
7.8.3 Teva Hypothyroidism Drugs Major Product Offerings
7.8.4 Teva Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Teva Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Hypothyroidism Drugs Major Product Offerings
7.9.4 Novartis Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Abbott
7.10.1 Abbott Company Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Hypothyroidism Drugs Major Product Offerings
7.10.4 Abbott Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Abbott Key News & Latest Developments
7.11 Roche
7.11.1 Roche Company Summary
7.11.2 Roche Hypothyroidism Drugs Business Overview
7.11.3 Roche Hypothyroidism Drugs Major Product Offerings
7.11.4 Roche Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Roche Key News & Latest Developments
7.12 Endo International
7.12.1 Endo International Company Summary
7.12.2 Endo International Hypothyroidism Drugs Business Overview
7.12.3 Endo International Hypothyroidism Drugs Major Product Offerings
7.12.4 Endo International Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Endo International Key News & Latest Developments
7.13 Ipsen
7.13.1 Ipsen Company Summary
7.13.2 Ipsen Hypothyroidism Drugs Business Overview
7.13.3 Ipsen Hypothyroidism Drugs Major Product Offerings
7.13.4 Ipsen Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Ipsen Key News & Latest Developments
7.14 ANI Pharmaceuticals
7.14.1 ANI Pharmaceuticals Company Summary
7.14.2 ANI Pharmaceuticals Business Overview
7.14.3 ANI Pharmaceuticals Hypothyroidism Drugs Major Product Offerings
7.14.4 ANI Pharmaceuticals Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.14.5 ANI Pharmaceuticals Key News & Latest Developments
7.15 TherapeuticsMD
7.15.1 TherapeuticsMD Company Summary
7.15.2 TherapeuticsMD Business Overview
7.15.3 TherapeuticsMD Hypothyroidism Drugs Major Product Offerings
7.15.4 TherapeuticsMD Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.15.5 TherapeuticsMD Key News & Latest Developments
8 Global Hypothyroidism Drugs Production Capacity, Analysis
8.1 Global Hypothyroidism Drugs Production Capacity, 2018-2029
8.2 Hypothyroidism Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Hypothyroidism Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hypothyroidism Drugs Supply Chain Analysis
10.1 Hypothyroidism Drugs Industry Value Chain
10.2 Hypothyroidism Drugs Upstream Market
10.3 Hypothyroidism Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hypothyroidism Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Hypothyroidism Drugs in Global Market
Table 2. Top Hypothyroidism Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hypothyroidism Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hypothyroidism Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Hypothyroidism Drugs Sales by Companies, (Units), 2018-2023
Table 6. Global Hypothyroidism Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hypothyroidism Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Hypothyroidism Drugs Product Type
Table 9. List of Global Tier 1 Hypothyroidism Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hypothyroidism Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Hypothyroidism Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Hypothyroidism Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hypothyroidism Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Hypothyroidism Drugs Sales (Units), 2018-2023
Table 15. By Type - Global Hypothyroidism Drugs Sales (Units), 2024-2029
Table 16. By Application – Global Hypothyroidism Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Hypothyroidism Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hypothyroidism Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Hypothyroidism Drugs Sales (Units), 2018-2023
Table 20. By Application - Global Hypothyroidism Drugs Sales (Units), 2024-2029
Table 21. By Region – Global Hypothyroidism Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Hypothyroidism Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hypothyroidism Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Hypothyroidism Drugs Sales (Units), 2018-2023
Table 25. By Region - Global Hypothyroidism Drugs Sales (Units), 2024-2029
Table 26. By Country - North America Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hypothyroidism Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Hypothyroidism Drugs Sales, (Units), 2018-2023
Table 29. By Country - North America Hypothyroidism Drugs Sales, (Units), 2024-2029
Table 30. By Country - Europe Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hypothyroidism Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Hypothyroidism Drugs Sales, (Units), 2018-2023
Table 33. By Country - Europe Hypothyroidism Drugs Sales, (Units), 2024-2029
Table 34. By Region - Asia Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hypothyroidism Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Hypothyroidism Drugs Sales, (Units), 2018-2023
Table 37. By Region - Asia Hypothyroidism Drugs Sales, (Units), 2024-2029
Table 38. By Country - South America Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hypothyroidism Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Hypothyroidism Drugs Sales, (Units), 2018-2023
Table 41. By Country - South America Hypothyroidism Drugs Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hypothyroidism Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Hypothyroidism Drugs Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Hypothyroidism Drugs Sales, (Units), 2024-2029
Table 46. Eli Lilly Company Summary
Table 47. Eli Lilly Hypothyroidism Drugs Product Offerings
Table 48. Eli Lilly Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Eli Lilly Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Hypothyroidism Drugs Product Offerings
Table 52. Pfizer Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie Hypothyroidism Drugs Product Offerings
Table 56. AbbVie Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. AbbVie Key News & Latest Developments
Table 58. Novo Nordisk Company Summary
Table 59. Novo Nordisk Hypothyroidism Drugs Product Offerings
Table 60. Novo Nordisk Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Novo Nordisk Key News & Latest Developments
Table 62. Merck KGaA Company Summary
Table 63. Merck KGaA Hypothyroidism Drugs Product Offerings
Table 64. Merck KGaA Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Merck KGaA Key News & Latest Developments
Table 66. Mylan Company Summary
Table 67. Mylan Hypothyroidism Drugs Product Offerings
Table 68. Mylan Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Mylan Key News & Latest Developments
Table 70. Bayer Company Summary
Table 71. Bayer Hypothyroidism Drugs Product Offerings
Table 72. Bayer Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Bayer Key News & Latest Developments
Table 74. Teva Company Summary
Table 75. Teva Hypothyroidism Drugs Product Offerings
Table 76. Teva Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Teva Key News & Latest Developments
Table 78. Novartis Company Summary
Table 79. Novartis Hypothyroidism Drugs Product Offerings
Table 80. Novartis Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Novartis Key News & Latest Developments
Table 82. Abbott Company Summary
Table 83. Abbott Hypothyroidism Drugs Product Offerings
Table 84. Abbott Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Abbott Key News & Latest Developments
Table 86. Roche Company Summary
Table 87. Roche Hypothyroidism Drugs Product Offerings
Table 88. Roche Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Roche Key News & Latest Developments
Table 90. Endo International Company Summary
Table 91. Endo International Hypothyroidism Drugs Product Offerings
Table 92. Endo International Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Endo International Key News & Latest Developments
Table 94. Ipsen Company Summary
Table 95. Ipsen Hypothyroidism Drugs Product Offerings
Table 96. Ipsen Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Ipsen Key News & Latest Developments
Table 98. ANI Pharmaceuticals Company Summary
Table 99. ANI Pharmaceuticals Hypothyroidism Drugs Product Offerings
Table 100. ANI Pharmaceuticals Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. ANI Pharmaceuticals Key News & Latest Developments
Table 102. TherapeuticsMD Company Summary
Table 103. TherapeuticsMD Hypothyroidism Drugs Product Offerings
Table 104. TherapeuticsMD Hypothyroidism Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. TherapeuticsMD Key News & Latest Developments
Table 106. Hypothyroidism Drugs Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 107. Global Hypothyroidism Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Hypothyroidism Drugs Production by Region, 2018-2023 (Units)
Table 109. Global Hypothyroidism Drugs Production by Region, 2024-2029 (Units)
Table 110. Hypothyroidism Drugs Market Opportunities & Trends in Global Market
Table 111. Hypothyroidism Drugs Market Drivers in Global Market
Table 112. Hypothyroidism Drugs Market Restraints in Global Market
Table 113. Hypothyroidism Drugs Raw Materials
Table 114. Hypothyroidism Drugs Raw Materials Suppliers in Global Market
Table 115. Typical Hypothyroidism Drugs Downstream
Table 116. Hypothyroidism Drugs Downstream Clients in Global Market
Table 117. Hypothyroidism Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hypothyroidism Drugs Segment by Type in 2022
Figure 2. Hypothyroidism Drugs Segment by Application in 2022
Figure 3. Global Hypothyroidism Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hypothyroidism Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hypothyroidism Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Hypothyroidism Drugs Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Hypothyroidism Drugs Revenue in 2022
Figure 9. By Type - Global Hypothyroidism Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Hypothyroidism Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Hypothyroidism Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Hypothyroidism Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Hypothyroidism Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Hypothyroidism Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Hypothyroidism Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Hypothyroidism Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Hypothyroidism Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Hypothyroidism Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Hypothyroidism Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Hypothyroidism Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Hypothyroidism Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Hypothyroidism Drugs Sales Market Share, 2018-2029
Figure 23. US Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Hypothyroidism Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Hypothyroidism Drugs Sales Market Share, 2018-2029
Figure 28. Germany Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Hypothyroidism Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Hypothyroidism Drugs Sales Market Share, 2018-2029
Figure 37. China Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Hypothyroidism Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Hypothyroidism Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Hypothyroidism Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Hypothyroidism Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Hypothyroidism Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Hypothyroidism Drugs Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Hypothyroidism Drugs by Region, 2022 VS 2029
Figure 54. Hypothyroidism Drugs Industry Value Chain
Figure 55. Marketing Channels

※参考情報

甲状腺機能低下症は、甲状腺が十分なホルモンを産生できない状態を指します。この病状は、体の新陳代謝や成長に関与する甲状腺ホルモンの不足により、様々な身体的および精神的な問題を引き起こす可能性があります。甲状腺機能低下症の治療には、主にチロキシンと呼ばれる合成ホルモンが用いられます。これにより、体内のホルモンレベルを正常化し、症状を改善することが可能となります。

甲状腺機能低下症は、全体的に見て女性に多く見られる病気であり、中高年層の人々に特に頻度が高いとされています。代表的な原因としては、自己免疫疾患であるハシモト病や、甲状腺の手術歴、放射線治療、または iodine（ヨード）の不足が挙げられます。これらの要因が甲状腺の機能を低下させ、ホルモンの産生を妨げます。

治療薬には主に合成ホルモン製剤が使用されます。この中で最も普及しているのは、レボチロキシン（商品名：チラミンなど）です。レボチロキシンは、体内で甲状腺ホルモンの主要成分であるチロキシン（T4）として作用し、エネルギーの代謝を促進し、身体の新陳代謝を調整します。患者によっては、副作用が生じることもありますが、一般的には安定した効果が期待できます。

こうした薬剤の特徴として、服用後の吸収が迅速であり、血中濃度が比較的安定していることが挙げられます。また、長期的な治療が必要となるため、服用スケジュールの統一性が求められます。習慣化を促進するためには、毎日朝食前に同じ時間に服用することが推奨されています。これにより、吸収率を最大限に高めることができ、必要なホルモン濃度を維持しやすくなります。

治療には他にも、ホルモンバランスを調整するサプリメントや栄養指導も含まれます。例えば、セレンや亜鉛といった微量ミネラルが甲状腺機能に欠かせない要素として知られています。これらのミネラルは、酵素の活性を助ける役割を果たし、甲状腺ホルモンの合成に寄与します。そのため、バランスの取れた食事を心掛けることも、治療の一環として重要です。

加えて、関連する技術として、血液検査によるホルモン濃度のモニタリングが挙げられます。日本では、TSH（甲状腺刺激ホルモン）とフリーホルモン（T3、T4）の測定が行われ、治療の効果や投与量の調整が評価されます。TSHの値が基準値の範囲内にあることが、適切な治療の指標となります。

また、新しい治療法として、甲状腺機能を支えるための補完療法も研究されています。例えば、メトホルミンという糖尿病薬が甲状腺機能に対する影響が議論されているほか、漢方薬などの伝統療法も一定の効果が見込まれると言われています。こうした代替療法は、患者にとって心理的な安心感をもたらすことがありますが、実際の治療効果には個人差があるため、医学的な観点からの評価が重要です。

最後に、甲状腺機能低下症の治療は、個別化医療の観点からも進化しています。特に、遺伝子解析技術の向上により、患者一人一人の体質に最適な治療法を提供する可能性が広がっています。医師は、患者の生活習慣や家族歴、病歴を総合的に考慮し、最適な治療計画を立てる必要があります。

このように、甲状腺機能低下症の治療は、ホルモン補充療法に加え、栄養管理、生活習慣の見直し、関連技術の活用など、多角的なアプローチが求められる分野です。患者は、自己管理を行いながら、適切な医療を受けることで、日常生活をより豊かに過ごすことができるでしょう。治療が成功することで、多くの方が健康的な生活を取り戻し、自分らしい毎日を送ることが期待されます。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 甲状腺機能低下症治療薬の世界市場見通し2023年-2029年(Hypothyroidism Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

甲状腺機能低下症治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp